Trials / Recruiting
RecruitingNCT04499898
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
Randomized Controlled Trial of Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding in Cirrhotic Patients With Arterial Hypertension
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 306 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension
Detailed description
A Randomized controlled trial of carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carvedilol | Carvedilol |
| PROCEDURE | Endoscopic band ligation | Endoscopic band ligation |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2030-12-01
- Completion
- 2030-12-10
- First posted
- 2020-08-05
- Last updated
- 2020-08-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04499898. Inclusion in this directory is not an endorsement.